Ortho Vision

Ortho Clinical Diagnostics (now part of QuidelOrtho) is a global leader in in vitro diagnostics (IVD), specializing in transfusion medicine and clinical laboratory solutions. The company is widely recognized for its flagship Ortho Vision platform, which provides fully automated immunohematology testing for blood banks and hospitals to ensure safe and compatible blood transfusions. Its extensive portfolio includes the Vitros line of integrated systems for clinical chemistry and immunodiagnostics, as well as a broad menu of assays for infectious diseases, cardiac markers, and metabolic conditions. Following its $6 billion acquisition by Quidel in 2022, the company operates as a core business unit within QuidelOrtho, continuing to drive innovation in automated laboratory workflows and diagnostic accuracy.